Home>Topics>Finance>Bill Ackman

Bill Ackman

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Ackman, Einhorn post strong returns in November -investors

    Headlines

    Mon, 1 Dec 2014

    BOSTON, Dec 1 (Reuters) - William Ackman , David Einhorn and Barry Rosenstein, three of the hedge fund industry's most-prominent stock pickers, posted strong returns

  2. Ackman's Pershing Square sees big payoff from Allergan deal

    Headlines

    Wed, 26 Nov 2014

    BOSTON (Reuters) - Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc., his firm's biggest bet of 2014.

  3. Ackman's Pershing Square still holds 26.6 million Allergan shares

    Headlines

    Wed, 26 Nov 2014

    BOSTON, Nov 26 (Reuters) - Hedge fund manager William Ackman told investors in a letter that his firm still owns 26.6 million shares in Allergan Inc. which were valued at $5.6 billion one week after...

  4. Ackman supports Allergan's $66 billion sale to Actavis

    Headlines

    Tue, 18 Nov 2014

    (Reuters) - Activist investor William Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder meeting.

  5. UPDATE 1-Ackman supports Allergan's $66 billion sale to Actavis

    Headlines

    Tue, 18 Nov 2014

    Nov 18 (Reuters) - Activist investor William Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special...

  6. Ackman says supports Allergan's $66 billion sale to Actavis -CNBC

    Headlines

    Tue, 18 Nov 2014

    Nov 18 (Reuters) - Activist investor William Ackman is supporting the $66 billion deal in which Actavis PLC will buy Allergan Inc and plans to withdraw from an Allergan special shareholder meeting he had planned, CNBC television reported on Tuesday.

  7. Allergan agrees to $66 billion Actavis offer; Valeant walks

    Headlines

    Mon, 17 Nov 2014

    (Reuters) - Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor William Ackman and Valeant Pharmaceuticals International Inc.

  8. UPDATE 4-Allergan agrees to $66 bln Actavis offer; Valeant walks

    Headlines

    Mon, 17 Nov 2014

    Nov 17 (Reuters) - Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc , ending a seven-month hostile pursuit by activist investor William Ackman and Valeant Pharmaceuticals International Inc.

  9. Allergan agrees to Actavis deal for $66 billion

    Headlines

    Mon, 17 Nov 2014

    Nov 17 (Reuters) - Allergan Inc agreed to be bought by Actavis Plc for $66 billion, more than $12 billion above the current value of a hostile bid by activist investor William Ackman and Valeant Pharmaceuticals International Inc .

  10. Actavis Beats Out Valeant’s Hostile Bid for Wide-Moat Allergan

    Commentary

    Mon, 17 Nov 2014

    for Allergan. We don’t anticipate Actavis’ $219 offer will spur a bidding war with Valeant and its partnership with Bill Ackman ’s Pershing Square, which was previously pursuing a hostile takeover with a last official bid near $180. Although we

« Prev12345Next »
Content Partners